You are here

  • Home
  • Archive
  • Volume 68, Issue 11
  • Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis

Authors

  1. Correspondence to Dr R-H Wong, Department of Public Health, Chung Shan Medical University, 110 Chien-Kuo N Rd, Sec 1, Taichung, Taiwan 40242; rueyhong{at}csmu.edu.tw
View Full Text

Citation

Wei JC, Lee H, Chen W, et al
Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis
Annals of the Rheumatic Diseases 2009;68:1781-1786.

Publication history

  • Accepted November 3, 2008
  • First published November 19, 2008.
Online issue publication 
March 04, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

BMJ Publishing Group Ltd and European League Against Rheumatism. All rights reserved.